So little money has been set aside by the NHS for the rollout of the Mounjaro weight-loss jab in GP surgeries that as few as one in five people with life-threatening obesity is likely to get treatment, new research shows.Read More

You might also be interested in reading EQS-DD: Dermapharm Holding SE: Wilhelm Beier, buy.